Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

The effect of vitamin D supplementation on plasma non-oxidised PTH in a randomised clinical trial.

Ursem SR, Francic V, Keppel M, Schwetz V, Trummer C, Pandis M, Aberer F, Grübler M, Verheyen ND, Maerz W, Tomaschitz A, Pilz S, Obermayer-Pietsch BR, Heijboer AC.

Endocr Connect. 2019 Apr 1. pii: EC-19-0097.R1. doi: 10.1530/EC-19-0097. [Epub ahead of print]

2.

Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study).

Grammer TB, Scharnagl H, Dressel A, Kleber ME, Silbernagel G, Pilz S, Tomaschitz A, Koenig W, Mueller-Myhsok B, März W, Strnad P.

Clin Chem. 2019 Jul;65(7):849-861. doi: 10.1373/clinchem.2018.297242. Epub 2019 Mar 27.

PMID:
30917972
3.

The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.

Keppel MH, Piecha G, März W, Cadamuro J, Auer S, Felder TK, Mrazek C, Oberkofler H, Trummer C, Grübler MR, Schwetz V, Verheyen N, Pandis M, Borzan V, Haschke-Becher E, Tomaschitz A, Pilz S.

PLoS One. 2019 Feb 28;14(2):e0212973. doi: 10.1371/journal.pone.0212973. eCollection 2019.

4.

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.

Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Düngen HD, Angermann CE, Hasenfuß G, Pieske B, Wachter R, Edelmann F.

ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19.

5.

Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts.

Aspelund T, Grübler MR, Smith AV, Gudmundsson EF, Keppel M, Cotch MF, Harris TB, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grove-Laugesen D, Rejnmark L, Swart KMA, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S, Gudnason V, Eiriksdottir G.

Nutrients. 2019 Jan 2;11(1). pii: E74. doi: 10.3390/nu11010074.

6.

Association of allostatic load with health-related quality of life in patients with arterial hypertension: a cross-sectional analysis.

Matzer F, Fazekas C, Vajda C, Pilz S, Schwetz V, Trummer C, Pandis M, Tomaschitz A, Petsch I, Obermayer-Pietsch B, Pieber T, Kapfhammer HP.

Swiss Med Wkly. 2018 Dec 15;148:w14689. doi: 10.4414/smw.2018.14689. eCollection 2018 Dec 3.

7.

Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.

Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grübler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A.

Front Endocrinol (Lausanne). 2018 Jul 17;9:373. doi: 10.3389/fendo.2018.00373. eCollection 2018. Review.

8.

Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.

Swart KM, Lips P, Brouwer IA, Jorde R, Heymans MW, Grimnes G, Grübler MR, Gaksch M, Tomaschitz A, Pilz S, Eiriksdottir G, Gudnason V, Wamberg L, Rejnmark L, Sempos CT, Durazo-Arvizu RA, Dowling KG, Hull G, Škrabáková Z, Kiely M, Cashman KD, van Schoor NM.

Am J Clin Nutr. 2018 Jun 1;107(6):1043-1053. doi: 10.1093/ajcn/nqy078.

9.

Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.

Pilz S, Trummer C, Verheyen N, Schwetz V, Pandis M, Aberer F, Grübler MR, Meinitzer A, Bachmann A, Voelkl J, Alesutan I, Catena C, Sechi LA, März W, Obermayer-Pietsch B, Tomaschitz A.

Horm Metab Res. 2018 May;50(5):375-382. doi: 10.1055/a-0604-3249. Epub 2018 May 3.

PMID:
29723896
10.

Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Voelkl J, Tuffaha R, Luong TTD, Zickler D, Masyout J, Feger M, Verheyen N, Blaschke F, Kuro-O M, Tomaschitz A, Pilz S, Pasch A, Eckardt KU, Scherberich JE, Lang F, Pieske B, Alesutan I.

J Am Soc Nephrol. 2018 Jun;29(6):1636-1648. doi: 10.1681/ASN.2017050492. Epub 2018 Apr 13.

11.

Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial.

Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S.

J Clin Lipidol. 2018 May - Jun;12(3):588-596.e4. doi: 10.1016/j.jacl.2018.03.079. Epub 2018 Mar 15.

PMID:
29653812
12.

Effects of vitamin D supplementation on FGF23: a randomized-controlled trial.

Trummer C, Schwetz V, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Steinkellner J, Friedl C, Brandenburg V, Voelkl J, Alesutan I, Obermayer-Pietsch B, Pieber TR, Tomaschitz A, Pilz S.

Eur J Nutr. 2019 Mar;58(2):697-703. doi: 10.1007/s00394-018-1672-7. Epub 2018 Mar 30.

13.

Vitamin D: Current Guidelines and Future Outlook.

Pilz S, Trummer C, Pandis M, Schwetz V, Aberer F, Grübler M, Verheyen N, Tomaschitz A, März W.

Anticancer Res. 2018 Feb;38(2):1145-1151. Review.

PMID:
29374751
14.

The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review.

van Ballegooijen AJ, Pilz S, Tomaschitz A, Grübler MR, Verheyen N.

Int J Endocrinol. 2017;2017:7454376. doi: 10.1155/2017/7454376. Epub 2017 Sep 12. Review.

15.

Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.

Verheyen N, Grübler MR, Meinitzer A, Trummer C, Schwetz V, Amrein K, Dimai HP, März W, Catena C, von Lewinski D, Voelkl J, Alesutan I, Fahrleitner-Pammer A, Brussee H, Pilz S, Tomaschitz A.

Bone. 2017 Dec;105:212-217. doi: 10.1016/j.bone.2017.08.030. Epub 2017 Sep 14.

PMID:
28918310
16.

Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.

Wetzel J, Pilz S, Grübler MR, Fahrleitner-Pammer A, Dimai HP, von Lewinski D, Kolesnik E, Perl S, Trummer C, Schwetz V, Meinitzer A, Belyavskiy E, Völkl J, Catena C, Brandenburg V, März W, Pieske B, Brussee H, Tomaschitz A, Verheyen ND.

J Clin Hypertens (Greenwich). 2017 Nov;19(11):1173-1180. doi: 10.1111/jch.13064. Epub 2017 Aug 20.

17.

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

Goliasch G, Silbernagel G, Kleber ME, Grammer TB, Pilz S, Tomaschitz A, Bartko PE, Maurer G, Koenig W, Niessner A, März W.

Sci Rep. 2017 Jul 5;7(1):4700. doi: 10.1038/s41598-017-04935-8.

18.

Effects of Vitamin D Supplementation on IGF-1 and Calcitriol: A Randomized-Controlled Trial.

Trummer C, Schwetz V, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Lang A, Friedl C, Tomaschitz A, Obermayer-Pietsch B, Pieber TR, Pilz S, Treiber G.

Nutrients. 2017 Jun 17;9(6). pii: E623. doi: 10.3390/nu9060623.

19.

Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.

Alesutan I, Voelkl J, Feger M, Kratschmar DV, Castor T, Mia S, Sacherer M, Viereck R, Borst O, Leibrock C, Gawaz M, Kuro-O M, Pilz S, Tomaschitz A, Odermatt A, Pieske B, Wagner CA, Lang F.

Sci Rep. 2017 May 17;7(1):2059. doi: 10.1038/s41598-017-01882-2.

20.

Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence.

Grübler MR, März W, Pilz S, Grammer TB, Trummer C, Müllner C, Schwetz V, Pandis M, Verheyen N, Tomaschitz A, Fiordelisi A, Laudisio D, Cipolletta E, Iaccarino G.

Rev Endocr Metab Disord. 2017 Jun;18(2):259-272. doi: 10.1007/s11154-017-9417-0. Review.

PMID:
28451877
21.

Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial.

Schwetz V, Trummer C, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Lang A, Treiber G, Friedl C, Obermayer-Pietsch B, Pieber TR, Tomaschitz A, Pilz S.

Nutrients. 2017 Apr 27;9(5). pii: E432. doi: 10.3390/nu9050432.

22.

Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.

Verheyen N, Meinitzer A, Grübler MR, Ablasser K, Kolesnik E, Fahrleitner-Pammer A, Belyavskiy E, Trummer C, Schwetz V, Pieske-Kraigher E, Voelkl J, Alesutan I, Catena C, Sechi LA, Brussee H, Lewinski DV, März W, Pieske B, Pilz S, Tomaschitz A.

Clin Chem Lab Med. 2017 Jun 27;55(7):1034-1042. doi: 10.1515/cclm-2016-1159.

PMID:
28432842
23.

Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.

Verheyen N, Fahrleitner-Pammer A, Belyavskiy E, Gruebler MR, Dimai HP, Amrein K, Ablasser K, Martensen J, Catena C, Pieske-Kraigher E, Colantonio C, Voelkl J, Lang F, Alesutan I, Meinitzer A, März W, Brussee H, Pieske B, Pilz S, Tomaschitz A.

PLoS One. 2017 Apr 13;12(4):e0173799. doi: 10.1371/journal.pone.0173799. eCollection 2017.

24.

Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Zelzer S, Enko D, Pilz S, Tomaschitz A, März W, Meinitzer A.

Clin Biochem. 2017 Sep;50(13-14):739-745. doi: 10.1016/j.clinbiochem.2017.03.013. Epub 2017 Mar 18.

PMID:
28322753
25.

Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium.

Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grübler M, Eiriksdottir G, Gudmundsson EF, Harris TB, Cotch MF, Aspelund T, Gudnason V, Rutters F, Beulens JW, van 't Riet E, Nijpels G, Dekker JM, Grove-Laugesen D, Rejnmark L, Busch MA, Mensink GB, Scheidt-Nave C, Thamm M, Swart KM, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S.

PLoS One. 2017 Feb 16;12(2):e0170791. doi: 10.1371/journal.pone.0170791. eCollection 2017.

26.

Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension.

Grübler MR, Gaksch M, Kienreich K, Verheyen ND, Schmid J, Müllner C, Richtig G, Scharnagl H, Trummer C, Schwetz V, Meinitzer A, Pieske B, März W, Tomaschitz A, Pilz S.

J Steroid Biochem Mol Biol. 2018 Jan;175:157-163. doi: 10.1016/j.jsbmb.2016.12.014. Epub 2016 Dec 24.

PMID:
28027911
27.

Beneficial Effects of UV-Radiation: Vitamin D and beyond.

Trummer C, Pandis M, Verheyen N, Grübler MR, Gaksch M, Obermayer-Pietsch B, Tomaschitz A, Pieber TR, Pilz S, Schwetz V.

Int J Environ Res Public Health. 2016 Oct 19;13(10). pii: E1028. Review.

28.

Clinical-Pathological Conference Series from the Medical University of Graz : Case No 160: 33-year-old woman with tetraparesis on Easter Sunday.

Fabian E, Schiller D, Tomaschitz A, Langner C, Pilz S, Quasthoff S, Raggam RB, Schoefl R, Krejs GJ.

Wien Klin Wochenschr. 2016 Oct;128(19-20):719-727. Epub 2016 Sep 28. No abstract available.

29.

Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.

Verheyen N, Fahrleitner-Pammer A, Pieske B, Meinitzer A, Belyavskiy E, Wetzel J, Gaksch M, Grübler MR, Catena C, Sechi LA, Van Ballegooijen AJ, Brandenburg VM, Scharnagl H, Perl S, Brussee H, März W, Pilz S, Tomaschitz A.

J Hypertens. 2016 Sep;34(9):1778-86. doi: 10.1097/HJH.0000000000001004.

PMID:
27379537
30.

The Renin-Angiotensin-Aldosterone System in Smokers and Non-Smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.

Delgado GE, Siekmeier R, Krämer BK, Grübler M, Tomaschitz A, März W, Kleber ME.

Adv Exp Med Biol. 2016;935:75-82. doi: 10.1007/5584_2016_39.

PMID:
27334735
31.

Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial.

Grübler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J, Ó Hartaigh B, Richtig G, Scharnagl H, Meinitzer A, Fahrleitner-Pammer A, März W, Tomaschitz A, Pilz S.

Diabetes Obes Metab. 2016 Oct;18(10):1006-12. doi: 10.1111/dom.12709. Epub 2016 Jul 28.

PMID:
27334070
32.

Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.

Catena C, Colussi G, Novello M, Verheyen ND, Bertin N, Pilz S, Tomaschitz A, Sechi LA.

Hypertension. 2016 Jul;68(1):204-12. doi: 10.1161/HYPERTENSIONAHA.116.07615. Epub 2016 May 31.

PMID:
27245179
33.

Vitamin D and cardiovascular disease prevention.

Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W.

Nat Rev Cardiol. 2016 Jul;13(7):404-17. doi: 10.1038/nrcardio.2016.73. Epub 2016 May 6. Review.

PMID:
27150190
34.

Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.

Grübler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J, Ó Hartaigh BW, Richtig G, Scharnagl H, Meinitzer A, Pieske B, Fahrleitner-Pammer A, März W, Tomaschitz A, Pilz S.

J Clin Hypertens (Greenwich). 2016 Jul;18(7):608-13. doi: 10.1111/jch.12825. Epub 2016 Apr 21.

35.

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Tomaschitz A, Verheyen N, Meinitzer A, Pieske B, Belyavskiy E, Brussee H, Haas J, März W, Pieske-Kraigher E, Verheyen S, Ofner-Ziegenfuss L, Hartaigh BÓ, Schwetz V, Aberer F, Grübler M, Lang F, Alesutan I, Voelkl J, Gaksch M, Horina JH, Dimai HP, Rus-Machan J, Stiegler C, Ritz E, Fahrleitner-Pammer A, Pilz S.

J Hypertens. 2016 Jul;34(7):1347-56. doi: 10.1097/HJH.0000000000000927.

PMID:
27065001
36.

Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial.

Ernst JB, Tomaschitz A, Grübler MR, Gaksch M, Kienreich K, Verheyen N, März W, Pilz S, Zittermann A.

Int J Endocrinol. 2016;2016:6836402. doi: 10.1155/2016/6836402. Epub 2016 Feb 23.

37.

Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.

Alesutan I, Feger M, Tuffaha R, Castor T, Musculus K, Buehling SS, Heine CL, Kuro-O M, Pieske B, Schmidt K, Tomaschitz A, Maerz W, Pilz S, Meinitzer A, Voelkl J, Lang F.

Cardiovasc Res. 2016 Jun 1;110(3):408-18. doi: 10.1093/cvr/cvw062. Epub 2016 Mar 21.

PMID:
27001421
38.

Vitamin D and Mortality.

Pilz S, Grübler M, Gaksch M, Schwetz V, Trummer C, Hartaigh BÓ, Verheyen N, Tomaschitz A, März W.

Anticancer Res. 2016 Mar;36(3):1379-87. Review.

PMID:
26977039
39.

GDF-15, soluble ST2 and Troponin-I: Biomarkers of Subclinical Vascular Disease?

Tomaschitz A, Pilz S, März W.

Atherosclerosis. 2016 May;248:255-6. doi: 10.1016/j.atherosclerosis.2016.02.008. Epub 2016 Feb 9. No abstract available.

PMID:
26972630
40.

Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.

Grübler MR, Kienreich K, Gaksch M, Verheyen N, Hartaigh BÓ, Fahrleitner-Pammer A, März W, Schmid J, Oberreither EM, Wetzel J, Catena C, Sechi LA, Pieske B, Tomaschitz A, Pilz S.

Medicine (Baltimore). 2016 Feb;95(8):e2794. doi: 10.1097/MD.0000000000002794.

41.

Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.

Verheyen ND, Kienreich K, Gaksch M, van Ballegooijen AJ, Grübler MR, Hartaigh BÓ, Schmid J, Fahrleitner-Pammer A, Kraigher-Krainer E, Colantonio C, Belyavskiy E, Treiber G, Catena C, Brussee H, Pieske B, März W, Tomaschitz A, Pilz S.

J Clin Hypertens (Greenwich). 2016 Jun;18(6):543-50. doi: 10.1111/jch.12710. Epub 2015 Oct 12.

42.

Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.

Brandenburg VM, Kleber ME, Vervloet MG, Larsson TE, Tomaschitz A, Pilz S, Stojakovic T, Delgado G, Grammer TB, Marx N, März W, Scharnagl H.

Atherosclerosis. 2015 Oct;242(2):483-9. doi: 10.1016/j.atherosclerosis.2015.08.017. Epub 2015 Aug 13.

PMID:
26298739
43.

Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.

Koller L, Kleber ME, Brandenburg VM, Goliasch G, Richter B, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer TB, Delgado G, Tomaschitz A, Pilz S, Berger R, Mörtl D, Hülsmann M, Pacher R, März W, Niessner A.

Circ Heart Fail. 2015 Nov;8(6):1059-67. doi: 10.1161/CIRCHEARTFAILURE.115.002341. Epub 2015 Aug 13.

PMID:
26273098
44.

Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.

Catena C, Verheyen ND, Url-Michitsch M, Kraigher-Krainer E, Colussi G, Pilz S, Tomaschitz A, Pieske B, Sechi LA.

Am J Hypertens. 2016 Mar;29(3):303-10. doi: 10.1093/ajh/hpv104. Epub 2015 Jul 10.

PMID:
26163660
45.

Homoarginine in the renal and cardiovascular systems.

Pilz S, Meinitzer A, Gaksch M, Grübler M, Verheyen N, Drechsler C, Hartaigh BÓ, Lang F, Alesutan I, Voelkl J, März W, Tomaschitz A.

Amino Acids. 2015 Sep;47(9):1703-13. doi: 10.1007/s00726-015-1993-2. Epub 2015 May 1. Review.

PMID:
25929587
46.

Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study.

Catena C, Verheyen N, Pilz S, Kraigher-Krainer E, Tomaschitz A, Sechi LA, Pieske B.

Hypertension. 2015 Jun;65(6):1231-7. doi: 10.1161/HYPERTENSIONAHA.115.05285. Epub 2015 Mar 23.

PMID:
25801873
47.

Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.

Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A.

Hypertension. 2015 Jun;65(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.115.05319. Epub 2015 Mar 23.

PMID:
25801871
48.

Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.

Tomaschitz A, Pilz S, Rus-Machan J, Meinitzer A, Brandenburg VM, Scharnagl H, Kapl M, Grammer T, Ritz E, Horina JH, Kleber ME, Pieske B, Kraigher-Krainer E, Hartaigh BÓ, Toplak H, van Ballegooijen AJ, Amrein K, Fahrleitner-Pammer A, März W.

Int J Cardiol. 2015 Apr 1;184:710-6. doi: 10.1016/j.ijcard.2015.03.062. Epub 2015 Mar 4.

PMID:
25777071
49.

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.

Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H.

Transplantation. 2015 Jul;99(7):1470-6. doi: 10.1097/TP.0000000000000568.

PMID:
25675199
50.

New genetic loci link adipose and insulin biology to body fat distribution.

Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JMW, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, Gustafsson S, Day FR, Esko T, Fall T, Kutalik Z, Luan J, Randall JC, Scherag A, Vedantam S, Wood AR, Chen J, Fehrmann R, Karjalainen J, Kahali B, Liu CT, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bragg-Gresham JL, Buyske S, Demirkan A, Ehret GB, Feitosa MF, Goel A, Jackson AU, Johnson T, Kleber ME, Kristiansson K, Mangino M, Leach IM, Medina-Gomez C, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Stančáková A, Sung YJ, Tanaka T, Teumer A, Van Vliet-Ostaptchouk JV, Yengo L, Zhang W, Albrecht E, Ärnlöv J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Blüher M, Böhringer S, Bonnet F, Böttcher Y, Bruinenberg M, Carba DB, Caspersen IH, Clarke R, Daw EW, Deelen J, Deelman E, Delgado G, Doney AS, Eklund N, Erdos MR, Estrada K, Eury E, Friedrich N, Garcia ME, Giedraitis V, Gigante B, Go AS, Golay A, Grallert H, Grammer TB, Gräßler J, Grewal J, Groves CJ, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heikkilä K, Herzig KH, Helmer Q, Hillege HL, Holmen O, Hunt SC, Isaacs A, Ittermann T, James AL, Johansson I, Juliusdottir T, Kalafati IP, Kinnunen L, Koenig W, Kooner IK, Kratzer W, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindström J, Lobbens S, Lorentzon M, Mach F, Magnusson PK, Mahajan A, McArdle WL, Menni C, Merger S, Mihailov E, Milani L, Mills R, Moayyeri A, Monda KL, Mooijaart SP, Mühleisen TW, Mulas A, Müller G, Müller-Nurasyid M, Nagaraja R, Nalls MA, Narisu N, Glorioso N, Nolte IM, Olden M, Rayner NW, Renstrom F, Ried JS, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Sennblad B, Seufferlein T, Sitlani CM, Smith AV, Stirrups K, Stringham HM, Sundström J, Swertz MA, Swift AJ, Syvänen AC, Tayo BO, Thorand B, Thorleifsson G, Tomaschitz A, Troffa C, van Oort FV, Verweij N, Vonk JM, Waite LL, Wennauer R, Wilsgaard T, Wojczynski MK, Wong A, Zhang Q, Zhao JH, Brennan EP, Choi M, Eriksson P, Folkersen L, Franco-Cereceda A, Gharavi AG, Hedman ÅK, Hivert MF, Huang J, Kanoni S, Karpe F, Keildson S, Kiryluk K, Liang L, Lifton RP, Ma B, McKnight AJ, McPherson R, Metspalu A, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Olsson C, Perry JR, Reinmaa E, Salem RM, Sandholm N, Schadt EE, Scott RA, Stolk L, Vallejo EE, Westra HJ, Zondervan KT; ADIPOGen Consortium; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GEFOS Consortium; GENIE Consortium; GLGC; ICBP; International Endogene Consortium; LifeLines Cohort Study; MAGIC Investigators; MuTHER Consortium; PAGE Consortium; ReproGen Consortium, Amouyel P, Arveiler D, Bakker SJ, Beilby J, Bergman RN, Blangero J, Brown MJ, Burnier M, Campbell H, Chakravarti A, Chines PS, Claudi-Boehm S, Collins FS, Crawford DC, Danesh J, de Faire U, de Geus EJ, Dörr M, Erbel R, Eriksson JG, Farrall M, Ferrannini E, Ferrières J, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gieger C, Gudnason V, Haiman CA, Harris TB, Hattersley AT, Heliövaara M, Hicks AA, Hingorani AD, Hoffmann W, Hofman A, Homuth G, Humphries SE, Hyppönen E, Illig T, Jarvelin MR, Johansen B, Jousilahti P, Jula AM, Kaprio J, Kee F, Keinanen-Kiukaanniemi SM, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuulasmaa K, Kuusisto J, Lakka TA, Langenberg C, Le Marchand L, Lehtimäki T, Lyssenko V, Männistö S, Marette A, Matise TC, McKenzie CA, McKnight B, Musk AW, Möhlenkamp S, Morris AD, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Palmer LJ, Penninx BW, Peters A, Pramstaller PP, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schwarz PE, Shuldiner AR, Staessen JA, Steinthorsdottir V, Stolk RP, Strauch K, Tönjes A, Tremblay A, Tremoli E, Vohl MC, Völker U, Vollenweider P, Wilson JF, Witteman JC, Adair LS, Bochud M, Boehm BO, Bornstein SR, Bouchard C, Cauchi S, Caulfield MJ, Chambers JC, Chasman DI, Cooper RS, Dedoussis G, Ferrucci L, Froguel P, Grabe HJ, Hamsten A, Hui J, Hveem K, Jöckel KH, Kivimaki M, Kuh D, Laakso M, Liu Y, März W, Munroe PB, Njølstad I, Oostra BA, Palmer CN, Pedersen NL, Perola M, Pérusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sinisalo J, Slagboom PE, Snieder H, Spector TD, Stefansson K, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Veronesi G, Walker M, Wareham NJ, Watkins H, Wichmann HE, Abecasis GR, Assimes TL, Berndt SI, Boehnke M, Borecki IB, Deloukas P, Franke L, Frayling TM, Groop LC, Hunter DJ, Kaplan RC, O'Connell JR, Qi L, Schlessinger D, Strachan DP, Thorsteinsdottir U, van Duijn CM, Willer CJ, Visscher PM, Yang J, Hirschhorn JN, Zillikens MC, McCarthy MI, Speliotes EK, North KE, Fox CS, Barroso I, Franks PW, Ingelsson E, Heid IM, Loos RJ, Cupples LA, Morris AP, Lindgren CM, Mohlke KL.

Nature. 2015 Feb 12;518(7538):187-196. doi: 10.1038/nature14132.

Supplemental Content

Loading ...
Support Center